These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3488563)
1. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA. Kilgore DP; Breger RK; Daniels DL; Pojunas KW; Williams AL; Haughton VM Radiology; 1986 Sep; 160(3):757-61. PubMed ID: 3488563 [TBL] [Abstract][Full Text] [Related]
2. Gd-DTPA in clinical MR of the brain: 2. Extraaxial lesions and normal structures. Berry I; Brant-Zawadzki M; Osaki L; Brasch R; Murovic J; Newton TH AJR Am J Roentgenol; 1986 Dec; 147(6):1231-5. PubMed ID: 3490759 [TBL] [Abstract][Full Text] [Related]
3. Gadolinium-DTPA enhancement of dural structures on MRI after surgery. Suzuki M; Takashima T; Kadoya M; Ueda F; Yamashima T; Yamashita J Neurochirurgia (Stuttg); 1992 Jul; 35(4):112-6. PubMed ID: 1508289 [TBL] [Abstract][Full Text] [Related]
4. Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. Brant-Zawadzki M; Berry I; Osaki L; Brasch R; Murovic J; Norman D AJR Am J Roentgenol; 1986 Dec; 147(6):1223-30. PubMed ID: 3490758 [TBL] [Abstract][Full Text] [Related]
5. MR imaging with Gd-DTPA in lesions of the head and neck. Vogl Th; Dresel S; Juergens M; Assal J; Lissner J J Otolaryngol; 1993 Aug; 22(4):220-30. PubMed ID: 8230372 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. Schmiedl U; Ogan MD; Moseley ME; Brasch RC AJR Am J Roentgenol; 1986 Dec; 147(6):1263-70. PubMed ID: 3535459 [TBL] [Abstract][Full Text] [Related]
11. Effect of dose and field strength on enhancement with paramagnetic contrast media. Lindsey RO; Yetkin FZ; Prost R; Haughton VM AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934 [TBL] [Abstract][Full Text] [Related]
12. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Revel D; Brasch RC; Paajanen H; Rosenau W; Grodd W; Engelstad B; Fox P; Winkelhake J Radiology; 1986 Feb; 158(2):319-23. PubMed ID: 2417274 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging. Niendorf HP; Felix R; Laniado M; Schörner W; Claussen C; Weinmann HJ Radiat Med; 1985; 3(1):7-12. PubMed ID: 4070676 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging. Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147 [TBL] [Abstract][Full Text] [Related]
17. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging. Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606 [TBL] [Abstract][Full Text] [Related]
18. MR contrast enhancement of intracranial lesions with Gd-DTPA. Hesselink JR; Press GA Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078 [TBL] [Abstract][Full Text] [Related]
19. Sequence of enhancement of various portions of the pituitary gland on gadolinium-enhanced MR images: correlation with regional blood supply. Tien RD AJR Am J Roentgenol; 1992 Mar; 158(3):651-4. PubMed ID: 1739013 [TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection. Bird CR; Drayer BP; Medina M; Rekate HL; Flom RA; Hodak JA Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]